Pediatric Caudal Injection Volume on Optic Nerve Sheath Diameter and Cerebral Oxygenation

June 29, 2022 updated by: Aybike Onur Gönen, Aybike Onur Gonen

The Effect of Caudal Epidural Injection Volume on Optic Nerve Sheath Diameter and Cerebral Oxygenation in Pediatric Cases

Caudal anesthesia is a commonly used neuraxial anesthesia method for children. Injection of a certain volume of fluid into the epidural space for cauda anesthesia may push some cerebrospinal fluid towards the head, which may lead to mild increase of pressures inside the head. Such mild changes are compensated well by healthy individuals and no clinical sequel is seen, however at-risk populations may be affected. We aim to see how different amounts of fluid injected into the epidural space may change two clinical parameters affected by intracranial pressure to determine if a lower volume is safer than a higher one.

Study Overview

Detailed Description

Caudal epidural injection of local anesthetic solution is a common neuraxial anesthesia technique that provides excellent peri-operative analgesia in children. Unfused sacral hiatus allows for easy and safe access into the epidural space. Anatomically, injection of a certain volume of fluid over the dural sac inside the closed spinal canal can push the cerebrospinal fluid cranially. This push may lead to increased intracranial pressure. We will measure two findings affected by intracranial pressure (optic nerve sheath diameter and cerebral oxygenation) and compare the effects of two different volumes of caudal injections on these measures.

Children with closed fontanelles and scheduled to undergo elective surgery, for which caudal anesthesia is an effective method for peri-operative analgesia, will be recruited for this study. Injection volume will be determined depending on the level of analgesia required for the surgical procedure. Ultrasonographic measurements of optic nerve sheath diameter and near-infrared spectrometry measurement of cerebral oxygenation will be taken before and after caudal anesthesia.

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34098
        • Istanbul University Cerrahpasa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 8 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ASA class 1 or 2
  • Scheduled for elective surgery suitable for caudal anesthesia
  • Parental/guardian consent for caudal anesthesia and measurements obtained
  • Closed fontanelles

Exclusion Criteria:

  • Open fontanelle
  • Parental/guardian refusal
  • Previous intracranial or ocular pathology
  • Coagulapathies
  • Variations in gross and ultrasonographic sacral anatomy
  • Block performence to end of surgery expected to last less than 30 minutes
  • Block volumes more than 30ml needed
  • Laparoscopic surgery
  • Need for long term analgesia with epidural catheter

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SCREENING
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Low Volume
Caudal anesthesia will be performed with 0.8 ml/kg of the local anesthetic solution
Caudal epidural injection will be performed after induction of general anesthesia.
ACTIVE_COMPARATOR: High Volume
Caudal anesthesia will be performed with 1.25 ml/kg of the local anesthetic solution
Caudal epidural injection will be performed after induction of general anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in optic nerve sheath diameter
Time Frame: From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Difference in the percentage change of ultrasonographic measurement of optic nerve sheath diameter between groups
From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Change in cerebral oxygenation
Time Frame: From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Difference in the change in near-infrared spectrometry measurement of cerebral oxygenation between the groups
From before caudal injection to immediately, 10 min, 20 min and 30 min after.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation in optic nerve sheath diameter
Time Frame: From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Difference in the percentage change of ultrasonographic measurement of optic nerve sheath diameter in each group
From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Variation in cerebral oxygenation
Time Frame: From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Difference in the change in near-infrared spectrometry measurement of cerebral oxygenation in each group
From before caudal injection to immediately, 10 min, 20 min and 30 min after.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in hemodynamic and respiratory parameters
Time Frame: From before caudal injection to immediately, 10 min, 20 min and 30 min after.
Mean arterial pressure, heart rate, end-tidal carbondioxide pressure, peak inspiratory pressure, peripheral oxygen saturation, oxygen fraction of inhaled gas
From before caudal injection to immediately, 10 min, 20 min and 30 min after.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Aybike Onur Gönen, MD, Istanbul University - Cerrahpasa (IUC)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 15, 2019

Primary Completion (ACTUAL)

March 15, 2022

Study Completion (ACTUAL)

March 15, 2022

Study Registration Dates

First Submitted

July 27, 2020

First Submitted That Met QC Criteria

July 27, 2020

First Posted (ACTUAL)

July 29, 2020

Study Record Updates

Last Update Posted (ACTUAL)

June 30, 2022

Last Update Submitted That Met QC Criteria

June 29, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No formal plans to share IPD is made

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatrics

Clinical Trials on Caudal anesthesia

Subscribe